This information was published on 2020-10-23T00:53:21 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2102319 (IR 1540236) |
| (220) |
09 Jun 2020
|
| (300) |
US, 22 May 2020, 88930205
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases. |
| (540) | RENJOZY |
| (550) | Word |
| (730) |
AMICUS THERAPEUTICS, INC.
|
Find out more about publications on the About page.